CDH2 and pancreatic neoplasm: We also found that compared with the sh mTOR group, activating the HGF/c-Met signaling pathway recovered the N-cadherin and Vimentin expression of pancreatic cancer cells but decreased the E-cadherin expression in the HGF + sh mTOR group (Fig. 5K–L and Supplementary Fig. S12A–J).